Lightnews — Scholar-powered news

Dave Weisman @dweisman.bsky.social · 7d

Weird case of Oxytocin helping with agitation.

journals.sagepub.com/doi/10.1177/...

Intranasal Oxytocin for Managing Agitation in a Patient of Mixed Dementia With Multiple Pathologies, Particularly With a History of Repetitive Head Injuries - Naresh Jadav, Sümeyye Kuş, James Ellison,...

Background Agitation is common in persons living with dementia (major neurocognitive disorder) and worsens with disease progression. Brexpiprazole is the sole F...

journals.sagepub.com

Dave Weisman @dweisman.bsky.social · 10d

Go Sid!

2

Dave Weisman @dweisman.bsky.social · 13d

He’s almost moving from a werewolf to aware wolf.

1

Dave Weisman @dweisman.bsky.social · 14d

This will be the first winner of the Ig-Nobel and the Nobel.

1

Dave Weisman @dweisman.bsky.social · 16d

Wrapping up Vermont riding.

1 3

Dave Weisman @dweisman.bsky.social · 16d

Join me in burning out more doctors.

1

Dave Weisman @dweisman.bsky.social · 29d

It is a trap.

1

Dave Weisman @dweisman.bsky.social · Sep 5

if you don’t laugh, you cry.

Dave Weisman @dweisman.bsky.social · Aug 27

Awesome.

1

Dave Weisman @dweisman.bsky.social · Aug 23

Meh, drop out over time will make the stats eventually overlap. You can make your point then. But 1.5 years of delayed treatment, then the lines look parallel to me.

Dave Weisman @dweisman.bsky.social · Aug 23

Great piece. I hope eventually @profrobhoward.bsky.social will turn sanguine.

1

Dave Weisman @dweisman.bsky.social · Aug 23

Then try to get NHS to pay for it. Because currently how many people in the UK are getting it? How many of them are URM by any measure?

Dave Weisman @dweisman.bsky.social · Aug 11

Another mouseheimer's paper blown up beyond all reason. Please, do not take Lithium for memory or Alzheimer's disease.

wapo.st/47uJMrU

How lithium went from 7Up to treatment for mental illness — and maybe Alzheimer’s

A new study suggests lithium may play a crucial role in developing Alzheimer’s treatments, but the substance has long been used to treat mood disorders like bipolar disorder.

wapo.st

1

Dave Weisman @dweisman.bsky.social · Aug 4

This is probably much better than 10 years ago. Still bad, but getting better.

1

Dave Weisman @dweisman.bsky.social · Aug 1

Does he know what productivity means? I can't point to a single advancement he made, helped with, or even a failed try.

1

Dave Weisman @dweisman.bsky.social · Jul 26

Hilarious photo.

I think I just saw Dr. Offit IRL during a mtn bike ride. I nodded but didn't approach because it would have been weird and I was only 90% sure.

Dave Weisman @dweisman.bsky.social · Jul 21

Check this conversation out on Neurology Live.

www.neurologylive.com/peers-perspe...

Approaches and Considerations in Mild Cognitive Impairment Due to Alzheimer

Experts discuss the importance of early diagnosis in Alzheimer disease, and discuss the safety and efficacy of newer treatment options for mild cognitive impairment.

www.neurologylive.com

Dave Weisman @dweisman.bsky.social · Jul 16

An unblinded story is a type of data.

Dave Weisman @dweisman.bsky.social · Jul 15

The basis of informed consent is falsifying medical records?

Dave Weisman @dweisman.bsky.social · Jul 13

Anti-vaxx ate my face party?

1

Dave Weisman @dweisman.bsky.social · Jul 11

How to implement anti-amyloid therapies lecanemab or donanemab:

practicalneurology.com/diseases-dia...

Building an Infrastructure to Administer Amyloid-Targeting Treatments

With the introduction of amyloid-targeting therapies, clinicians face a paradigm shift, requiring new clinical systems, interdisciplinary teams, and exper…

practicalneurology.com

1 1

Dave Weisman @dweisman.bsky.social · Jul 11

New titration of donanemab is approved. Not aware of anyone who use the previous titration, but good to see this.

www.biospace.com/policy/lilly...

Lilly Gets FDA Label Update for Alzheimer’s Drug To Mitigate Safety Concerns

The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of the monoclonal antibody drug class that has led to several deaths.

www.biospace.com

2 5

Dave Weisman @dweisman.bsky.social · Jul 10

Philly.

Dave Weisman @dweisman.bsky.social · Jul 10

Radiologists are fast learners in this regard. Especially when you write "on anti-amyloid therapy, eval for ARIA before dose 5" on the order.

That said, I've had to call after baseline MRIs showing "a few" microhemes. Like dude, this is 2025, where do you think we are, England?

Dave Weisman @dweisman.bsky.social · Jul 9

I also left Twitter. So I'm just as likely to come across an NPR article here, perhaps more so.

3